Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei.

Jenkins CH, Wallis R, Allcock N, Barnes KB, Richards MI, Auty JM, Galyov EE, Harding SV, Mukamolova GV.

Sci Rep. 2019 Jul 30;9(1):11060. doi: 10.1038/s41598-019-47483-z.

2.

Characterization of Flagellotropic, Chi-Like Salmonella Phages Isolated from Thai Poultry Farms.

Phothaworn P, Dunne M, Supokaivanich R, Ong C, Lim J, Taharnklaew R, Vesaratchavest M, Khumthong R, Pringsulaka O, Ajawatanawong P, Klumpp J, Brown N, Imam M, Clokie MRJ, Galyov EE, Korbsrisate S.

Viruses. 2019 Jun 5;11(6). pii: E520. doi: 10.3390/v11060520.

3.

Temperature-dependent virus lifecycle choices may reveal and predict facets of the biology of opportunistic pathogenic bacteria.

Egilmez HI, Morozov AY, Clokie MRJ, Shan J, Letarov A, Galyov EE.

Sci Rep. 2018 Jun 25;8(1):9642. doi: 10.1038/s41598-018-27716-3.

4.

Analyses of the Distribution Patterns of Burkholderia pseudomallei and Associated Phages in Soil Samples in Thailand Suggest That Phage Presence Reduces the Frequency of Bacterial Isolation.

Withatanung P, Chantratita N, Muangsombut V, Saiprom N, Lertmemongkolchai G, Klumpp J, Clokie MR, Galyov EE, Korbsrisate S.

PLoS Negl Trop Dis. 2016 Sep 26;10(9):e0005005. doi: 10.1371/journal.pntd.0005005. eCollection 2016 Sep.

5.

Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.

Lazar Adler NR, Stevens MP, Dean RE, Saint RJ, Pankhania D, Prior JL, Atkins TP, Kessler B, Nithichanon A, Lertmemongkolchai G, Galyov EE.

PLoS One. 2015 Apr 1;10(4):e0121271. doi: 10.1371/journal.pone.0121271. eCollection 2015.

6.

Temperature dependent bacteriophages of a tropical bacterial pathogen.

Shan J, Korbsrisate S, Withatanung P, Adler NL, Clokie MR, Galyov EE.

Front Microbiol. 2014 Nov 14;5:599. doi: 10.3389/fmicb.2014.00599. eCollection 2014.

7.

Correction: Identification of a Predicted Trimeric Autotransporter Adhesin Required for Biofilm Formation of Burkholderia pseudomallei.

Lazar Adler NR, Dean RE, Saint RJ, Stevens MP, Prior JL, Atkins TP, Galyov EE.

PLoS One. 2014 Jan 9;9(1). doi: 10.1371/annotation/f016476b-5b84-4c9a-899f-fe8b8bc927b5. eCollection 2014.

8.

Identification of a predicted trimeric autotransporter adhesin required for biofilm formation of Burkholderia pseudomallei.

Lazar Adler NR, Dean RE, Saint RJ, Stevens MP, Prior JL, Atkins TP, Galyov EE.

PLoS One. 2013 Nov 5;8(11):e79461. doi: 10.1371/journal.pone.0079461. eCollection 2013. Erratum in: PLoS One. 2014 Jan 9;9(1):.

9.

Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant.

Srinon V, Muangman S, Imyaem N, Muangsombut V, Lazar Adler NR, Galyov EE, Korbsrisate S.

J Microbiol. 2013 Aug;51(4):522-6. doi: 10.1007/s12275-013-2557-3. Epub 2013 Aug 30.

PMID:
23990305
10.

BopC is a type III secreted effector protein of Burkholderia pseudomallei.

Muangman S, Korbsrisate S, Muangsombut V, Srinon V, Adler NL, Schroeder GN, Frankel G, Galyov EE.

FEMS Microbiol Lett. 2011 Oct;323(1):75-82. doi: 10.1111/j.1574-6968.2011.02359.x. Epub 2011 Aug 10.

11.

Autotransporters and Their Role in the Virulence of Burkholderia pseudomallei and Burkholderia mallei.

Lazar Adler NR, Stevens JM, Stevens MP, Galyov EE.

Front Microbiol. 2011 Jul 15;2:151. doi: 10.3389/fmicb.2011.00151. eCollection 2011.

12.

Isolation and characterization of a novel podovirus which infects burkholderia pseudomallei.

Gatedee J, Kritsiriwuthinan K, Galyov EE, Shan J, Dubinina E, Intarak N, Clokie MR, Korbsrisate S.

Virol J. 2011 Jul 26;8:366. doi: 10.1186/1743-422X-8-366.

13.

Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Tippayawat P, Pinsiri M, Rinchai D, Riyapa D, Romphruk A, Gan YH, Houghton RL, Felgner PL, Titball RW, Stevens MP, Galyov EE, Bancroft GJ, Lertmemongkolchai G.

Infect Immun. 2011 Jan;79(1):305-13. doi: 10.1128/IAI.00803-10. Epub 2010 Nov 1.

14.

Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.

Galyov EE, Brett PJ, DeShazer D.

Annu Rev Microbiol. 2010;64:495-517. doi: 10.1146/annurev.micro.112408.134030. Review.

PMID:
20528691
15.

Salicylidene acylhydrazide-mediated inhibition of type III secretion system-1 in Salmonella enterica serovar Typhimurium is associated with iron restriction and can be reversed by free iron.

Layton AN, Hudson DL, Thompson A, Hinton JC, Stevens JM, Galyov EE, Stevens MP.

FEMS Microbiol Lett. 2010 Jan;302(2):114-22. doi: 10.1111/j.1574-6968.2009.01847.x. Epub 2009 Nov 6.

16.

Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei.

Gnanam AJ, Hall B, Shen X, Piasecki S, Vernados A, Galyov EE, Smither SJ, Kitto GB, Titball RW, Ellington AD, Brown KA.

Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S55-7. doi: 10.1016/S0035-9203(08)70015-4.

17.

Identification of novel genes and pathways affecting Salmonella type III secretion system 1 using a contact-dependent hemolysis assay.

Field TR, Layton AN, Bispham J, Stevens MP, Galyov EE.

J Bacteriol. 2008 May;190(9):3393-8. doi: 10.1128/JB.01189-07. Epub 2008 Feb 29.

19.

Identification of the Salmonella enterica serotype typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium.

Wall DM, Nadeau WJ, Pazos MA, Shi HN, Galyov EE, McCormick BA.

Cell Microbiol. 2007 Sep;9(9):2299-313. Epub 2007 May 18.

PMID:
17697195
20.

Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications.

Layton AN, Galyov EE.

Expert Rev Mol Med. 2007 Jul 2;9(18):1-17. Review.

PMID:
17605831
21.

Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors.

Hudson DL, Layton AN, Field TR, Bowen AJ, Wolf-Watz H, Elofsson M, Stevens MP, Galyov EE.

Antimicrob Agents Chemother. 2007 Jul;51(7):2631-5. Epub 2007 May 14.

22.

Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD.

Johnson S, Roversi P, Espina M, Olive A, Deane JE, Birket S, Field T, Picking WD, Blocker AJ, Galyov EE, Picking WL, Lea SM.

J Biol Chem. 2007 Feb 9;282(6):4035-44. Epub 2006 Oct 31.

23.

Salmonella typhimurium infection triggers dendritic cells and macrophages to adopt distinct migration patterns in vivo.

Zhao C, Wood MW, Galyov EE, Höpken UE, Lipp M, Bodmer HC, Tough DF, Carter RW.

Eur J Immunol. 2006 Nov;36(11):2939-50.

24.

A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.

Haque A, Chu K, Easton A, Stevens MP, Galyov EE, Atkins T, Titball R, Bancroft GJ.

J Infect Dis. 2006 Nov 1;194(9):1241-8. Epub 2006 Sep 25.

PMID:
17041850
25.

Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion system.

Roversi P, Johnson S, Field T, Deane JE, Galyov EE, Lea SM.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Sep 1;62(Pt 9):861-4. Epub 2006 Aug 11.

26.

Actin-dependent movement of bacterial pathogens.

Stevens JM, Galyov EE, Stevens MP.

Nat Rev Microbiol. 2006 Feb;4(2):91-101. Review.

PMID:
16415925
27.
28.

The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases.

Ungewickell A, Hugge C, Kisseleva M, Chang SC, Zou J, Feng Y, Galyov EE, Wilson M, Majerus PW.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18854-9. Epub 2005 Dec 19.

29.
30.

The Salmonella translocated effector SopA is targeted to the mitochondria of infected cells.

Layton AN, Brown PJ, Galyov EE.

J Bacteriol. 2005 May;187(10):3565-71.

31.

Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei.

Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, Hawes P, Monaghan P, Welch MD, Galyov EE.

Mol Microbiol. 2005 Apr;56(1):40-53.

32.
33.
34.

Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.

Stevens MP, Haque A, Atkins T, Hill J, Wood MW, Easton A, Nelson M, Underwood-Fowler C, Titball RW, Bancroft GJ, Galyov EE.

Microbiology. 2004 Aug;150(Pt 8):2669-76.

PMID:
15289563
35.

Exploitation of host cells by Burkholderia pseudomallei.

Stevens MP, Galyov EE.

Int J Med Microbiol. 2004 Apr;293(7-8):549-55. Review.

PMID:
15149030
36.

Structural analysis of Salmonella enterica effector protein SopD.

Wood MW, Williams C, Upadhyay A, Gill AC, Philippe DL, Galyov EE, van den Elsen JM, Bagby S.

Biochim Biophys Acta. 2004 May 6;1698(2):219-26.

PMID:
15134655
37.

Biophysical characterization of the catalytic domain of guanine nucleotide exchange factor BopE from Burkholderia pseudomallei.

Upadhyay A, Williams C, Gill AC, Philippe DL, Davis K, Taylor LA, Stevens MP, Galyov EE, Bagby S.

Biochim Biophys Acta. 2004 Apr 8;1698(1):111-9.

PMID:
15063321
38.

Assignment of the 1H, 13C and 15N resonances of the catalytic domain of guanine nucleotide exchange factor BopE from Burkholderia pseudomallei.

Wu HL, Williams C, Upadhyay A, Galyov EE, Bagby S.

J Biomol NMR. 2004 Jun;29(2):215-6. No abstract available.

PMID:
15014239
39.
40.

Assignment of the 1H, 13C and 15N resonances of the catalytic domain of guanine nucleotide exchange factor SopE2 from Salmonella dublin.

Williams C, Galyov EE, Bagby S.

J Biomol NMR. 2003 Aug;26(4):379-80. No abstract available.

PMID:
12815267
41.

An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.

Stevens MP, Wood MW, Taylor LA, Monaghan P, Hawes P, Jones PW, Wallis TS, Galyov EE.

Mol Microbiol. 2002 Nov;46(3):649-59.

42.

Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane.

Ruiz-Albert J, Yu XJ, Beuzón CR, Blakey AN, Galyov EE, Holden DW.

Mol Microbiol. 2002 May;44(3):645-61.

43.

The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis.

Wood MW, Jones MA, Watson PR, Siber AM, McCormick BA, Hedges S, Rosqvist R, Wallis TS, Galyov EE.

Cell Microbiol. 2000 Aug;2(4):293-303.

PMID:
11207586
44.

Differential cytokine expression in avian cells in response to invasion by Salmonella typhimurium, Salmonella enteritidis and Salmonella gallinarum.

Kaiser P, Rothwell L, Galyov EE, Barrow PA, Burnside J, Wigley P.

Microbiology. 2000 Dec;146 Pt 12:3217-26.

PMID:
11101679
45.

Molecular basis of Salmonella-induced enteritis.

Wallis TS, Galyov EE.

Mol Microbiol. 2000 Jun;36(5):997-1005. Review.

46.
47.

The Salmonella YopJ-homologue AvrA does not possess YopJ-like activity.

Schesser K, Dukuzumuremyi JM, Cilio C, Borg S, Wallis TS, Pettersson S, Galyov EE.

Microb Pathog. 2000 Feb;28(2):59-70.

PMID:
10644492
48.

Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.

Leary SE, Griffin KF, Galyov EE, Hewer J, Williamson ED, Holmström A, Forsberg A, Titball RW.

Microb Pathog. 1999 Mar;26(3):159-69.

PMID:
10089156
49.

SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase.

Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14057-9.

50.

Secreted effector proteins of Salmonella dublin act in concert to induce enteritis.

Jones MA, Wood MW, Mullan PB, Watson PR, Wallis TS, Galyov EE.

Infect Immun. 1998 Dec;66(12):5799-804.

Supplemental Content

Loading ...
Support Center